Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
KRC 
Kilroy Realty Corp (KRC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/30/2025: KRC (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
17 Analysts rated it
These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.
Year Target Price $38.6
Year Target Price $38.6
| 2 | Strong Buy |
| 2 | Buy |
| 12 | Hold |
| 0 | Under performing |
| 1 | Sell |
Analysis of Past Performance
Type Stock | Historic Profit 29.03% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 06/30/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.16B USD | Price to earnings Ratio 20.71 | 1Y Target Price 38.6 |
Price to earnings Ratio 20.71 | 1Y Target Price 38.6 | ||
Volume (30-day avg) 17 | Beta 1.21 | 52 Weeks Range 26.65 - 41.84 | Updated Date 06/29/2025 |
52 Weeks Range 26.65 - 41.84 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 6.21% | Basic EPS (TTM) 1.68 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 17.74% | Operating Margin (TTM) 27.27% |
Management Effectiveness
Return on Assets (TTM) 1.82% | Return on Equity (TTM) 3.94% |
Valuation
Trailing PE 20.71 | Forward PE 29.24 | Enterprise Value 8665152447 | Price to Sales(TTM) 3.68 |
Enterprise Value 8665152447 | Price to Sales(TTM) 3.68 | ||
Enterprise Value to Revenue 7.68 | Enterprise Value to EBITDA 12.12 | Shares Outstanding 118281000 | Shares Floating 107554899 |
Shares Outstanding 118281000 | Shares Floating 107554899 | ||
Percent Insiders 1 | Percent Institutions 124.26 |
Analyst Ratings
Rating 4 | Target Price 38.6 | Buy 2 | Strong Buy 2 |
Buy 2 | Strong Buy 2 | ||
Hold 12 | Sell 1 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Kilroy Realty Corp
Company Overview
History and Background
Kilroy Realty Corporation was founded in 1947 and is a real estate investment trust (REIT) focused on developing, acquiring, and managing office and life science properties in the West Coast markets.
Core Business Areas
- Office Properties: Leasing and managing office spaces primarily to technology, life science, and media companies. Kilroy's offices are mainly located in California, Washington, and Texas.
- Life Science Properties: Development and leasing of lab and office spaces tailored for life science tenants.
Leadership and Structure
John F. Kilroy, Jr. serves as the Chairman and CEO. The company has a traditional corporate structure with executive leadership overseeing various departments like acquisitions, development, leasing, and property management.
Top Products and Market Share
Key Offerings
- Office Space Leasing: Provides Class A office space leasing in prime locations. Market share data is fragmented across the West Coast markets. Competitors include Boston Properties (BXP), Alexandria Real Estate Equities (ARE), and Hudson Pacific Properties (HPP).
- Life Science Space Leasing: Offers specialized lab and office facilities for biotech and pharmaceutical companies. Competitors include Alexandria Real Estate Equities (ARE) and BioMed Realty (acquired by Blackstone).
Market Dynamics
Industry Overview
The REIT industry, particularly office and life science, is experiencing fluctuations due to hybrid work models and evolving demand. Life science remains robust but office is more uncertain.
Positioning
Kilroy Realty Corp is a prominent player in West Coast office and life science real estate, known for its high-quality properties and tenant relationships. Competitive advantages include prime locations and a focus on innovation-driven sectors.
Total Addressable Market (TAM)
The TAM for commercial real estate, including office and life science, is in the hundreds of billions. Kilroy's position in the West Coast market represents a significant portion of this, with ongoing opportunities in key innovation hubs.
Upturn SWOT Analysis
Strengths
- Prime Locations in High-Growth Markets
- Strong Tenant Relationships
- High-Quality Property Portfolio
- Expertise in Life Science Real Estate
- Strong Development Pipeline
Weaknesses
- Geographic Concentration (West Coast)
- Exposure to Economic Fluctuations
- High Debt Levels
- Vulnerability to Interest Rate Hikes
Opportunities
- Expanding Life Science Portfolio
- Developing New Sustainable Buildings
- Capitalizing on Hybrid Work Trends
- Acquiring Distressed Assets
- Expanding into New West Coast Markets
Threats
- Economic Recession
- Increased Interest Rates
- Increased Competition
- Decline in Demand for Office Space
- Regulatory Changes
Competitors and Market Share
Key Competitors
- BXP
- ARE
- HPP
- SL Green Realty Corp (SLG)
- Vornado Realty Trust (VNO)
Competitive Landscape
Kilroy offers high-quality assets and a West Coast focus. It faces competition from larger, diversified REITs and specialized life science developers.
Major Acquisitions
Dropbox Headquarters
- Year: 2021
- Acquisition Price (USD millions): 1080
- Strategic Rationale: Expanded presence in San Francisco tech market.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by development and acquisitions in core markets.
Future Projections: Future growth dependent on market conditions, interest rates, and leasing activity.
Recent Initiatives: Focus on life science development and sustainable building practices.
Summary
Kilroy Realty Corp is a West Coast-focused REIT with a strong presence in office and life science properties. Its strengths include prime locations and tenant relationships. However, geographic concentration and economic sensitivity pose risks. Recent initiatives focus on expanding the life science portfolio and sustainable building practices.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Analyst Estimates
- SEC Filings
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share are estimates and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Kilroy Realty Corp
Exchange NYSE | Headquaters Los Angeles, CA, United States | ||
IPO Launch date 1997-01-28 | CEO & Director Ms. Angela M. Aman | ||
Sector Real Estate | Industry REIT - Office | Full time employees 229 | Website https://www.kilroyrealty.com |
Full time employees 229 | Website https://www.kilroyrealty.com | ||
Kilroy is a leading U.S. landlord and developer, with operations in San Diego, Los Angeles, the San Francisco Bay Area, Seattle, and Austin. The Company has earned global recognition for sustainability, building operations, innovation, and design. As a pioneer and innovator in the creation of a more sustainable real estate industry, the Company's approach to modern business environments helps drive creativity and productivity for some of the world's leading technology, entertainment, life science, and business services companies. The Company is a publicly traded real estate investment trust ("REIT") and member of the S&P MidCap 400 Index with more than seven decades of experience developing, acquiring, and managing office, life science, and mixed-use projects. As of March 31, 2025, Kilroy's stabilized portfolio totaled approximately 17.1 million square feet of primarily office and life science space that was 81.4% occupied and 83.9% leased. The Company also had approximately 1,000 residential units in Hollywood and San Diego, which had a quarterly average occupancy of 95.2%. In addition, the Company had one development project in the tenant improvement phase totaling approximately 875,000 square feet with a total estimated investment of $1.0 billion and two life science redevelopment projects in the tenant improvement phase totaling approximately 100,000 square feet with total estimated redevelopment costs of $80.0 million.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.